Cirrhosis: CT and MR imaging evaluation
Introduction
Cirrhosis is the final result of chronic damage to the liver from various etiologies, characterized by parenchymal injury leading to extensive fibrosis and nodular regeneration. The result is a diffuse disorganization of hepatic morphology with progressive loss of liver function. Although the mortality rate has been reduced by about 30% in the last few decades, within the European Union cirrhosis is still one of the leading causes of death and serious morbidity. Cirrhosis is most commonly the result of hepatitis B and C virus infection or chronic alcoholism; other causes are biliary, cryptogenic and metabolic. Usual clinical manifestations result from portal hypertension, portosystemic shunting and hepatic insufficiency. Common complications are ascites, gastrointestinal bleeding, encephalopathy and coagulopathy.
In this review, we present the CT and MR imaging findings in the cirrhotic liver.
Section snippets
Liver morphology
At an early stage of cirrhosis, the liver may appear normal on cross sectional imaging. With disease progression, heterogeneity of liver parenchyma and surface nodularity are observed. Caudate lobe hypertrophy is the most characteristic morphologic feature of liver cirrhosis (Fig. 1). A ratio of transverse caudate lobe width to right lobe width greater than or equal to 0.65 constitutes a positive indicator for the diagnosis of cirrhosis with high level of accuracy [1]. A modified caudate lobe
Portal hypertension and mesenteric edema
In chronic liver disease, progressive hepatic fibrosis leads to increased vascular resistance at the level of the hepatic sinusoids. The increased pressure gradient is defined as portal hypertension, and causes complications such as ascites and the development of engorged and tortuous collateral vessels that typically develop at the lower end of the esophagus (Figs. 3C and 5A) and at the gastric fundus (hypertensive gastropathy) (Fig. 5B) [8]. The paraumbilical veins (Fig. 5C) and the left
Fibrosis
Fibrosis is an inherent part of hepatic cirrhosis, and is typically detected as patchy fibrosis (Fig. 1A), as a lacelike pattern, or as a confluent mass. The lacelike type of fibrosis is best described as thin or thick bands that surround regenerative nodules. This pattern is best visualized on nonenhanced CT (Fig. 4A), and is usually not well visualized on portal venous phase images (Fig. 4B) [10]. It is seen in about one-third of patients with primary biliary cirrhosis [7], regardless of
Regenerative nodules
In the cirrhotic liver, regenerative nodules are macronodular (≥9 mm), as usually seen in chronic hepatitis B, or micronodular (3–9 mm), as seen in other causes of cirrhosis. Most regenerative nodules are difficult to detect at CT or MR because they are too small or are too similar to surrounding liver parenchyma [13]. Computed tomography detects regenerative nodules when they are surrounded by hypodense fibrotic bands on nonenhanced CT (Fig. 4A) or when they accumulate iron (siderotic nodules)
Dysplastic nodules
Dysplastic nodules are regenerative nodules containing atypical cells without definite histological signs of malignancy, and are considered an intermediate, premalignant step along the hepatocarcinogenesis process. Malignant transformation within a dysplastic nodule has been identified as early as 4 months after the first detection of the dysplastic nodule [15]. Dysplastic nodules are found in 15–25% of cirrhotic livers at the time of transplantation and are subclassified on the basis of the
Hepatocellular carcinoma
Hepatocellular carcinoma typically occurs within the cirrhotic liver. As the degree of (de-differentiation) malignancy increases, portal blood supply decreases, whereas nontriadal arteries (i.e., unaccompanied by portal venules and biliary ducts) develop to feed the nodules. The presence of early arterial enhancement with rapid washout during the portal venous phase should be regarded as highly suspicious for the presence of hepatocellular carcinoma. Characteristically, hepatocellular carcinoma
Arterially enhancing nodules and perfusion anomalies
With the increasing use of thin section CT and MR imaging and the rapid bolus injection of contrast, small enhancing nodules and perfusion anomalies are increasingly being observed in the cirrhotic liver [28], [29]. Both nodules and perfusion anomalies are likely due to intrahepatic shunts between a hepatic arterial branch and the portal venous system. These pseudolesions may simulate a hypervascular hepatic lesion on the arterial dominant phase, and are not detectable on portal venous and
Hemangiomas
In the cirrhotic liver, hemangiomas are more difficult to recognize radiologically and pathologically. Progressive fibrosis alters the blood supply of the liver and causes loss of some identifying characteristics of hemangiomas, such as nodular peripheral enhancement and isoattenuation to blood vessels. Usually, however, the characteristic feature of high signal intensity on heavily T2-weighted images remains, helping to distinguish hemangioma from hepatocellular lesions. Fibrosis also causes
Peribiliary cysts
Peribiliary cysts are cystic lesions typically found on both sides of the intrahepatic portal venous branches. These lesions may have variable size and morphology: linear and confluent “tube-like” aspect, coursing adjacent to right or left portal vein, simulating dilated bile ducts, or linear cluster (“string of beads”) of cysts, with a prominent involvement of the left-sided intrahepatic ducts. They represent cystic dilatation of the extramural glands in the periductal connective tissue, and
Diseases that mimic cirrhosis
Several disease processes may result in distorted hepatic morphology that might be misinterpreted as cirrhosis on imaging.
In congenital hepatic fibrosis, the liver generally shows variable segmental hypertrophy or atrophy, with caudate lobe and left lateral segment enlargement and right lobe atrophy observed. However, as opposed to cirrhosis, the left medial segment is of normal size or enlarged (Fig. 17). This morphologic finding has been considered useful in distinguishing patients with
Summary
Both CT and MR provide valuable insights into the extent of hepatic injury from cirrhosis and complications including portal hypertension. Distinction among small hepatic focal lesions remains challenging, while both CT and MR are quite accurate in detection and characterization of larger (>2 cm) lesions, including hepatocellular carcinoma. Attention to scan technique is key, including the use of multiphasic imaging with a rapid IV bolus of contrast medium.
References (40)
- et al.
Computed tomographic imaging of hepatocellular carcinoma
Gastroenterology
(2004) - et al.
Magnetic resonance imaging of hepatocellular carcinoma
Gastroenterology
(2004) - et al.
Clinical management of hepatocellular carcinoma
Conclusions of the Barcelona-2000 EASL conference
J Hepatol
(2001) - et al.
Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis
Radiology
(1980) - et al.
Cirrhosis: modified caudate-right lobe ratio
Radiology
(2002) - et al.
Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US
Radiology
(1998) - et al.
Right posterior hepatic notch sign: a simple diagnostic MR sign of cirrhosis
J Magn Reson Imag
(2003) - et al.
Expanded gallbladder fossa: simple MR imaging sign of cirrhosis
Radiology
(1999) - et al.
End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients
Radiology
(1999) - et al.
Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients
Radiology
(2001)
Ultrasound of diffuse liver disease and portal hypertension
Eur Radiol
Mesenteric, omental, and retroperitoneal edema in cirrhosis: frequency and spectrum of CT findings
Radiology
Spectrum of imaging findings of the liver in end-stage cirrhosis. Part I. Gross morphology and diffuse abnormalities
AJR
Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging
Radiology
Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT
Radiology
MR imaging of cirrhotic nodules
Abdom Imag
Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging
Radiology
Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging
J Comput Assist Tomogr
Terminology of nodular hepatocellular lesions
Hepatology
Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images
Radiology
Cited by (131)
Detecting liver cirrhosis in computed tomography scans using clinically-inspired and radiomic features
2023, Computers in Biology and MedicineErrors and Misinterpretations in Imaging of Chronic Liver Diseases
2021, Magnetic Resonance Imaging Clinics of North AmericaNon-invasive diagnosis of severe alcoholic hepatitis: Usefulness of cross-sectional imaging
2021, Diagnostic and Interventional ImagingImaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver
2021, Magnetic Resonance ImagingCitation Excerpt :Rarely, a small HCC can exhibit an atypical imaging finding because the conserved blood supply leads to the appearance of an isointense lesion during the portal and delayed phases, in the absence of washout [56]. In patients with cirrhosis, the fibrotic architecture of the liver can cause distortion and involution of lesions; in such cases, a hemangioma may become hypovascular [3,7]. To overcome these potential pitfalls, it is necessary to obtain certain sequences: the first is T2-weighted imaging, on which rapidly filling hemangiomas appear strongly hyperintense [49,50].